Enrolling study
Investigational Treatment for Type 2 Diabetes
A research study evaluating an investigational medication in adults living with type 2 diabetes who are already taking a stable diabetes regimen.
About this study
This study looks at how an investigational medication is processed by the body and how it affects blood sugar measures over time. Participation is entirely voluntary, and study-related visits, laboratory work, and assessments are provided at no cost to you.
- Condition
- Type 2 Diabetes
- Age range
- 18–75
- Estimated duration
- About 12 months
- Study visits
- 9
Eligibility snapshot
- Adults 18–75 years of age
- Diagnosed with type 2 diabetes for at least 6 months
- Currently on a stable diabetes treatment regimen
- Able to attend scheduled visits at our research site
What to expect
- 1An initial screening visit to review eligibility and the informed consent document
- 2Approximately 9 study visits over the course of participation
- 3Routine laboratory work, vital signs, and questionnaires at study visits
- 4Ongoing contact with a study coordinator between visits
Compensation
Compensation for time and travel may be available.
Location & Principal Investigator
8500 Example Medical Plaza, Suite 210, Miami, FL 33176
Studies at this site are conducted by our Principal Investigators and research staff.
Frequently asked questions
Answers to questions we hear most often.
What does participation involve?
Participation involves scheduled study visits with assessments defined by the protocol. Everything that will be asked of you is described in the informed consent document before you decide.
How long is the study?
The estimated duration is listed above. Your coordinator will review the full visit schedule with you during the consent process.
Will I be compensated for time and travel?
Where compensation is offered, the amount and payment schedule are described in the informed consent document and reviewed with you before enrollment.
What are the eligibility requirements?
The listing above shows a high-level snapshot. Full criteria are defined in the protocol and confirmed by the study team at a screening visit.
Can I leave the study at any time?
Yes. Participation is voluntary and you may withdraw at any time. Your coordinator will discuss any recommended safety follow-up.
Is my information kept confidential?
Yes. Access is limited to delegated study staff, and information shared with the sponsor is coded wherever the protocol allows.
Think you may qualify?
Contact us to learn more. A short conversation is all it takes to find out whether a screening visit makes sense.
Contact us to pre-screenThis study is conducted under IRB oversight in accordance with Good Clinical Practice guidelines. Eligibility is confirmed by the study team; the information here is a summary and not a full protocol.